PCM
GMED icon

Prelude Capital Management’s Globus Medical GMED Stock Holding History

Prelude Capital Management’s Portfolio GMED Stock Details GMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-200
Closed -$10K – 2027
2020
Q2 		$10K Buy
+200
New +$9.65K ﹤0.01% 1577

Other funds holding GMED

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Prelude Capital Management's GMED Position: Q4 2023 in Review

Prelude Capital Management sold out of Globus Medical (GMED) in Q4 2023, closing a stake of 8,911 shares — an estimated $442K sold.

Prelude Capital Management first reported a position in GMED in Q4 2013 and held it in 26 quarters. The position peaked at $1.02M in Q1 2022. 408 funds tracked by Wall St. Rank hold GMED as of Q4 2023.

  • Prelude Capital Management reported no remaining Globus Medical position as of Q4 2023 after selling out during the quarter.
  • Prelude Capital Management sold 8,911 Globus Medical shares in Q4 2023, an estimated $442K.
  • Prelude Capital Management first reported a position in Globus Medical in Q4 2013 and held it in 26 quarters.
  • Prelude Capital Management's Globus Medical position peaked at $1.02M in Q1 2022.
  • 408 funds tracked by Wall St. Rank held Globus Medical as of Q4 2023.

Based on Prelude Capital Management's 13F filing for Q4 2023, filed 14 Feb 2024.